Search Results

No Results

    See all results

    Sorry, I don't understand. Please try again
    1. EMEA Innovative Medicine /
    2. JANSSEN REPORTS TOP-LINE PHASE 3 RESULTS FOR TREMFYA® (GUSELKUMAB) IN ADULTS WITH ACTIVE PSORIATIC ARTHRITIS

    JANSSEN REPORTS TOP-LINE PHASE 3 RESULTS FOR TREMFYA® (GUSELKUMAB) IN ADULTS WITH ACTIVE PSORIATIC ARTHRITIS

    Janssen Reports Top-Line Phase 3 Results For Tremfya® (Guselkumab) In Adults With Active Psoriatic Arthritis